| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b6e27a3ea2994580ad3ff077912b413 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 |
| filingDate |
2014-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f3c2a057f1811da1ad42fdaa7e5688a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26e7bc89546fc6e2e572d850187f3eeb |
| publicationDate |
2016-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016228364-A1 |
| titleOfInvention |
Pharmaceutical preparation of carbohydrates for therapeutic use |
| abstract |
The disclosure provides methods for preparation of carbohydrate replacement therapies (CRT) that include nanocarriers of carbohydrates and glycolipids for pharmaceutical delivery to cell interior, endoplasmic reticulum, and Golgi for treating CDG type I and CDG type II diseases as well as other metabolic disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113873998-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11058637-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11234933-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020205530-A1 |
| priorityDate |
2013-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |